Lyka Labs Limited has informed the Exchange about General Updates

Nclt Scheme FiledStrategic Transactions View source PDF Explain this filing

LYKALABS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.3%Reaction day

₹117.60

prior close

₹118.28

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.1%-0.2% vs market

Pharmaceuticals peers, median of 147sector-0.1%-0.3% vs sector

On the reaction day the stock moved 0.2 pts less than Nifty Microcap 250 and 0.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.1

15m

-0.1

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.3-0.1-0.2-0.1-0.3

Next day

-0.8+0.5-1.3-0.3-0.5

-1.4+1.1-2.5-0.0-1.3

-2.2+1.0-3.2+0.2-2.4

-2.2+1.4-3.6+0.1-2.3

+5.3+1.7+3.6+0.4+4.9

+2.0+2.1-0.1-0.3+2.4

15d

+1.0+3.9-2.9+1.4-0.5

-5.4+1.2-6.6-2.7-2.7

-3.2+6.7-9.9+1.5-4.7

-14.3+2.7-16.9-1.0-13.3

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 147Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Lyka Labs Limited has provided an update on its ongoing Scheme of Amalgamation with Lyka Exports Limited (Transferor Company), where Lyka Labs is the Transferee Company. The Joint Petition was originally filed on 12th March 2025 before the NCLT Ahmedabad Bench under Sections 230-232 of the Companies Act, 2013. The hearing originally listed for 15th May 2025 has been adjourned, and the next hearing is now scheduled for 12th June 2025. No approval or rejection has been issued yet, and the order from the 15th May hearing has only been uploaded as an adjournment notice.

Likely market impact

This is a routine procedural update with no material change. Shareholders should note that the amalgamation process is still pending and the next key milestone is the 12th June 2025 hearing. Until the scheme is approved, no impact on shareholding or capital structure should be assumed.